UpHealth Beheer

Beheer criteriumcontroles 2/4

De CEO UpHealth is Jay Jennings, benoemd in Jul2024, heeft een ambtstermijn van minder dan een jaar. De totale jaarlijkse vergoeding van { bedraagt $ 748.84K, bestaande uit 40.7% salaris en 59.3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.14% van de aandelen van het bedrijf, ter waarde $ 51.35. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 0.8 jaar en 3.4 jaar.

Belangrijke informatie

Jay Jennings

Algemeen directeur

US$748.8k

Totale compensatie

Percentage CEO-salaris	40.7%
Dienstverband CEO	less than a year
Eigendom CEO	0.1%
Management gemiddelde ambtstermijn	less than a year
Gemiddelde ambtstermijn bestuur	3.4yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Jay Jennings's beloning veranderd ten opzichte van UpHealth's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Mar 31 2024	n/a	n/a	-US$56m
Dec 31 2023	US$749k	US$305k	-US$58m
Sep 30 2023	n/a	n/a	-US$81m
Jun 30 2023	n/a	n/a	-US$226m
Mar 31 2023	n/a	n/a	-US$220m
Dec 31 2022	US$438k	US$290k	-US$223m

Compensatie versus markt: De totale vergoeding ($USD 748.84K ) Jay } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 650.80K ).

Compensatie versus inkomsten: De vergoeding van Jay is gestegen terwijl het bedrijf verliesgevend is.

CEO

Jay Jennings (57 yo)

less than a year

Tenure

US$748,836

Compensatie

Mr. Jay W. Jennings, CPA, serves as an Active Chief Executive Officer of UpHealth, Inc. from July 11, 2024. Mr. Jennings was Chief Financial Officer of UpHealth, Inc. from October 09, 2023 until August 202...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Jay Jennings	Active Chief Executive Officer	less than a year	US$748.84k	0.14% $ 51.4
Mariya Pylypiv	Co-Founder & Director	no data	US$215.00k	3.59% $ 1.4k
Chirinjeev Kathuria	Co-Founder & Director	no data	US$215.00k	20.36% $ 7.7k
Jordan DeMarie	VP of Administration & Compliance	less than a year	geen gegevens	geen gegevens
Jeremy Livianu	Chief Legal & Compliance Officer	1.8yrs	geen gegevens	geen gegevens
Lisa Fluxman	President of TTC Healthcare	2.8yrs	geen gegevens	geen gegevens
Michael Clark	Executive Vice President of Finance & Shared Services	less than a year	geen gegevens	geen gegevens
Ragen Stone	Executive Vice President Of Nursing	less than a year	geen gegevens	geen gegevens
Salvatore Aiello	VP of Revenue & Growth	less than a year	geen gegevens	geen gegevens
Kristina Netherland	Executive Vice President of Clinical Services	less than a year	geen gegevens	geen gegevens

0.8yrs

Gemiddelde duur

49.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van UPHL wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 0.8 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Mariya Pylypiv	Co-Founder & Director	3.4yrs	US$215.00k	3.59% $ 1.4k
Chirinjeev Kathuria	Co-Founder & Director	3.4yrs	US$215.00k	20.36% $ 7.7k
James Greene	Independent Director	less than a year	geen gegevens	geen gegevens
Avishay Katz	Independent Non-Executive Chairman of the Board	5.8yrs	US$675.50k	2.46% $ 931.5
Luis Machuca	Independent Director	1.9yrs	US$336.67k	0.13% $ 50.5
Agnes Rey-Giraud	Independent Director	3.4yrs	US$252.50k	0.0059% $ 2.2
Raluca Dinu	Independent Director	5.7yrs	US$265.50k	0.070% $ 26.7
Mark Guinan	Independent Director	1.9yrs	US$316.67k	0.13% $ 50.5

3.4yrs

Gemiddelde duur

60.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van UPHL wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.4 jaar).

UpHealth Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Uphealth, Inc. Elects James Greene as Director

UpHealth, Inc., Annual General Meeting, Dec 27, 2023

Uphealth, Inc. Announces CFO Changes

Uphealth, Inc. Announces Board Changes

High number of new and inexperienced directors

UpHealth, Inc., Announces Resignation of Ramesh Balakrishnan as President and Chief Strategy Officer

Recent updates

UpHealth, Inc. announced delayed 10-Q filing

UpHealth, Inc. announced delayed 10-Q filing

UpHealth, Inc. announced delayed 10-Q filing

UpHealth, Inc. announced delayed annual 10-K filing

GTCR LLC completed the acquisition of Cloudbreak Health, LLC from UpHealth, Inc. (NYSE:UPH).

NYSE Grants UpHealth's Request for A Hearing Before the CFR

Uphealth, Inc. Elects James Greene as Director

NYSE Regulation Determines to Commence Proceedings to Delist the UpHealth's Common Stock

NYSE Regulation Determines to Commence Proceedings to Delist the UpHealth's Common Stock

UpHealth, Inc., Annual General Meeting, Dec 27, 2023

UpHealth, Inc. Reports Impairment of Goodwill, Intangible Assets, and Other Long-Lived Assets for the Third Quarter Ended September 30, 2023

GTCR LLC entered into a membership interests purchase agreement to acquire Cloudbreak Health, LLC from UpHealth, Inc. (NYSE:UPH) for approximately $180 million.

GTCR LLC entered into a membership interests purchase agreement to acquire Cloudbreak Health, LLC from UpHealth, Inc. (NYSE:UPH) for approximately $180 million.

UpHealth, Inc. announced delayed 10-Q filing

Uphealth, Inc. Announces CFO Changes

Uphealth, Inc. Announces Board Changes

UpHealth, Inc.(NYSE:UPH) dropped from S&P TMI Index

Price target increased by 11% to US$7.02

Consensus EPS estimates fall by 30%, revenue upgraded

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

UpHealth, Inc. Revises Earnings Guidance for the Year 2023

UpHealth, Inc. to Report Q2, 2023 Results on Aug 10, 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

UpHealth, Inc. to Report Q1, 2023 Results on May 11, 2023

Full year 2022 earnings: EPS misses analyst expectations

Analysts Just Shaved Their UpHealth, Inc. (NYSE:UPH) Forecasts Dramatically

Consensus revenue estimates fall by 11%

Full year 2022 earnings: EPS misses analyst expectations

High number of new and inexperienced directors

UpHealth, Inc., Announces Resignation of Ramesh Balakrishnan as President and Chief Strategy Officer

UpHealth FQ3 revenue misses

UpHealth, Inc. Appoints Timothy Wilde as Chief Technology Officer

UpHealth says reverse stock split to effect changes to warrant terms

Uphealth, Inc. Announces Executive Appointments

UpHealth, Inc., Annual General Meeting, Dec 05, 2022

UpHealth, Inc. announced delayed 10-Q filing

Uphealth Inc. Announces Appointment of Melissa Frieswick, as Chief Growth Officer

Uphealth, Inc. Appoints Mahesh Inder Veer Singh as Executive Vice President

Consensus EPS estimates fall by 25%

UpHealth, Inc. announced that it has received $67.5 million in funding

UpHealth: The SPAC Disaster 'Du Jour'

Price target decreased to US$3.50

No longer forecast to breakeven

UpHealth Q2 2022 Earnings Preview

UpHealth Provides Information to Shareholders

UpHealth, Inc Announces Board Changes

UpHealth, Inc. Appoints Samuel J. Meckey as Chief Executive Officer

Jeffery Bray Provides Information to Shareholders of UpHealth Inc

Jeffery R. Bray Sends an Email to Shareholders of UpHealth

UpHealth Inc Communicates with Shareholders

UpHealth, Inc. Announces Board Changes

Mariya Pylypiv Discloses its Views on UpHealth

UpHealth, Inc. Appoints Daniel Mandoli as Executive Vice President of U.S. Services, Effective June 13, 2022

UpHealth: Troubled Virtual Healthcare Provider Still Searching For Answers

UpHealth Receives Non-Compliance Notice from NYSE

UpHealth, Inc. announced delayed 10-Q filing

UpHealth Announces Samuel J. Meckey as Chief Executive Officer, Effective July 2022

UpHealth, Inc. Provides Unaudited Earnings Guidance for the Year Ended December 31, 2022

UpHealth, Inc., Annual General Meeting, Jun 28, 2022

UpHealth, Inc. announced delayed annual 10-K filing

These Analysts Think UpHealth, Inc.'s (NYSE:UPH) Sales Are Under Threat

UpHealth, Inc. Provides Earnings Guidance for the Full Year 2022

UpHealth, Inc. Releases Martti™ Translation, Expanding Language Access Offering

UpHealth Is A Great Bargain At These Levels

Co-Founder recently bought US$102k worth of stock

Why UpHealth Has 300% Upside

Forecast to breakeven in 2023

UpHealth: Interesting But Difficult To Value

Less than half of directors are independent